We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
Cap. Flow
-$301M
Cap. Flow %
-3.99%
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$25.4M
2
ABBV icon
AbbVie
ABBV
+$21.9M
3
KYNB
Kyntra Bio
KYNB
+$19.2M
4
WM icon
Waste Management
WM
+$19M
5
GILD icon
Gilead Sciences
GILD
+$17.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 18.27%
3 Financials 10.05%
4 Consumer Discretionary 9.39%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SU icon
451
Suncor Energy
SU
$75.6B
$2.19M 0.03%
69,233
-35,547
-34% -$1.07M
VCYT icon
452
Veracyte
VCYT
$4.44B
$2.19M 0.03%
91,062
+9,500
+12% +$253K
WDAY icon
453
Workday
WDAY
$36.4B
$2.18M 0.03%
12,837
+1,892
+17% +$365K
NGM
454
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$2.15M 0.03%
155,000
+20,000
+15% +$300K
HAL icon
455
Halliburton
HAL
$26.8B
$2.13M 0.03%
113,087
+36,809
+48% +$762K
SPR
456
DELISTED
Spirit AeroSystems
SPR
$2.13M 0.03%
25,916
+56
+0.2% +$4.38K
GWW icon
457
W.W. Grainger
GWW
$66B
$2.1M 0.03%
7,060
-1,955
-22% -$544K
IVZ icon
458
Invesco
IVZ
$13.3B
$2.1M 0.03%
123,745
+73,548
+147% +$1.3M
KURA icon
459
Kura Oncology
KURA
$901M
$2.1M 0.03%
138,100
-224,000
-62% -$3.99M
DOV icon
460
Dover
DOV
$27.7B
$2.08M 0.03%
20,848
+3,051
+17% +$293K
BXP icon
461
Boston Properties
BXP
$11B
$2.07M 0.03%
15,944
-848
-5% -$110K
KR icon
462
Kroger
KR
$35.5B
$2.07M 0.03%
80,155
+5,851
+8% +$136K
XRX icon
463
Xerox
XRX
$357M
$2.05M 0.03%
68,438
-14,310
-17% -$448K
IBN icon
464
ICICI Bank
IBN
$107B
$2.04M 0.03%
167,588
+448
+0.3% +$5.25K
DLTR icon
465
Dollar Tree
DLTR
$24.1B
$2.02M 0.03%
17,649
+1,193
+7% +$125K
NUE icon
466
Nucor
NUE
$56.4B
$1.98M 0.03%
38,892
-7,198
-16% -$376K
SLF icon
467
Sun Life Financial
SLF
$46B
$1.98M 0.03%
44,141
+6,950
+19% +$290K
ESS icon
468
Essex Property Trust
ESS
$18.7B
$1.97M 0.03%
6,029
-852
-12% -$266K
MTD icon
469
Mettler-Toledo International
MTD
$27B
$1.96M 0.03%
2,786
-138
-5% -$101K
SNA icon
470
Snap-on
SNA
$21.1B
$1.95M 0.03%
12,463
+133
+1% +$20.4K
LUMN icon
471
Lumen
LUMN
$6.45B
$1.95M 0.03%
156,276
+8,335
+6% +$99K
VRSK icon
472
Verisk Analytics
VRSK
$27.1B
$1.93M 0.03%
12,183
-8,973
-42% -$1.39M
VLO icon
473
Valero Energy
VLO
$90.5B
$1.93M 0.03%
22,586
-160,211
-88% -$13M
NTRS icon
474
Northern Trust
NTRS
$22.4B
$1.92M 0.03%
20,533
-10,283
-33% -$944K
DLR icon
475
Digital Realty Trust
DLR
$72.4B
$1.92M 0.03%
14,749
-853
-5% -$104K

Similar funds

Candriam SCA's Q3 2019 Portfolio in Review

As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.

  • Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
  • Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
  • Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
  • Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
  • Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
  • Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
  • Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.